FibriCheck, a CE-mark and FDA-approved medical app, has launched the first smartwatch app that automatically monitors users’ heart rhythms during their sleep. The app, which can be integrated into any brand of smartwatch, detects episodes of both intermittent and silent atrial fibrillation.
A press release reports that FibriCheck’s latest innovation offers an easy and effective solution for detecting atrial fibrillation. It adds that this represents a unique opportunity for smartwatch manufacturers to add genuine value to their products in the form of potentially life-saving, built-in technology.
Smartwatches with the FibriCheck app installed automatically measure heart rhythm every five minutes during sleep. When a user wakes up, they have instant access to a detailed overview along with notifications which you can forward to your doctor for follow-up and/or treatment. Until now, atrial fibrillation could only be detected via medical examinations in a clinical setting.
Lars Grieten, CEO of FibriCheck comments: “Our goal is to make it as easy as possible for people to know if they have a heart rhythm irregularity, to prevent atrial fibrillation strokes from happening. The FibriCheck heart rhythm app is a device-agnostic medical software application that can easily be integrated into any phone or wearable product that uses PPG (photoplethysmography) sensors. For smartphone, smartwatch and consumer technology companies, this opens up new possibilities to expand product offerings and provide consumers with innovative ways to manage their health and health-related conditions, including better heart health.”
At present, the new medical smartwach app is undergoing the final stages of user testing and will be available for smartwatch manufacturers worldwide as of the second half of 2020. One major smartwatch manufacturer has already reached an agreement to integrate the FibriCheck technology in their products.